U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258914) titled 'Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)' on Sept. 08.
Brief Summary: Depression is a common complication of Autism Spectrum Disorder (ASD): it is four times more prevalent in people with ASD than in the general population.
However, treating depression in people with ASD is complicated by the lack of guidelines. Antidepressants appear to be less effective and less well tolerated than in the general population.
rTMS (repetitive transcranial magnetic stimulation) is a technique that stimulates the brain in a painless and non-invasive way. This technique is well tolerated and has v...